Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Construction of Novel lncRNA-miRNA-mRNA Network Associated With Recurrence and Identification of Immune-Related Potential Regulatory Axis in Hepatocellular Carcinoma. | Front Oncol | 2021 | 34336642 | PubTator, text mining | PubMed |
| Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies. | J Immunother Cancer | 2021 | 34330764 | PubTator, text mining | PubMed |
| The Many Faces of JAKs and STATs Within the COVID-19 Storm. | Front Immunol | 2021 | 34326843 | PubTator, text mining | PubMed |
| Associations between Exposure to Organochlorine Chemicals and Endometriosis: A Systematic Review of Experimental Studies and Integration of Epidemiological Evidence. | Environ Health Perspect | 2021 | 34310196 | PubTator, text mining | PubMed |
| Identification of Arp2/3 Complex Subunits as Prognostic Biomarkers for Hepatocellular Carcinoma. | Front Mol Biosci | 2021 | 34307456 | PubTator, text mining | PubMed |
| Role of Macrophages and Related Cytokines in Kidney Disease. | Front Med (Lausanne) | 2021 | 34307414 | PubTator, text mining | PubMed |
| In Vivo Induction of Regulatory T Cells Via CTLA-4 Signaling Peptide to Control Autoimmune Encephalomyelitis and Prevent Disease Relapse. | Adv Sci (Weinh) | 2021 | 34306974 | PubTator, text mining | PubMed |
| Examining the Effector Mechanisms of the Feishu Acupoint (BL13) in the Treatment of Pneumonia Based on Systematic Acupuncture and Moxibustion Research. | Evid Based Complement Alternat Med | 2021 | 34306143 | PubTator, text mining | PubMed |
| P2RY14 Is a Potential Biomarker of Tumor Microenvironment Immunomodulation and Favorable Prognosis in Patients With Head and Neck Cancer. | Front Genet | 2021 | 34306014 | PubTator, text mining | PubMed |
| Allergic Aspects of IgG4-Related Disease: Implications for Pathogenesis and Therapy. | Front Immunol | 2021 | 34305927 | PubTator, text mining | PubMed |
| Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease. | Int J Mol Sci | 2021 | 34299236 | PubTator, text mining | PubMed |
| Bacterial Infection and Non-Hodgkin B-Cell Lymphoma: Interactions between Pathogen, Host and the Tumor Environment. | Int J Mol Sci | 2021 | 34298992 | PubTator, text mining | PubMed |
| Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma. | Thorac Cancer | 2021 | 34297484 | PubTator, text mining | PubMed |
| CELF2 is a candidate prognostic and immunotherapy biomarker in triple-negative breast cancer and lung squamous cell carcinoma: A pan-cancer analysis. | J Cell Mol Med | 2021 | 34288370 | PubTator, text mining | PubMed |
| Inhibition of Orthotopic Genital Cancer Induced by Subcutaneous Administration of Human Papillomavirus Peptide Vaccine with CpG Oligodeoxynucleotides as an Adjuvant in Mice. | Cancer Manag Res | 2021 | 34285577 | PubTator, text mining | PubMed |
| Correlation between vascular endothelial growth factor pathway and immune microenvironment in head and neck squamous cell carcinoma. | BMC Cancer | 2021 | 34284746 | PubTator, text mining | PubMed |
| Biomarkers for Comorbidities Modulate the Activity of T-Cells in COPD. | Int J Mol Sci | 2021 | 34281240 | PubTator, text mining | PubMed |
| Lung Epithelial Signaling Mediates Early Vaccine-Induced CD4+ T Cell Activation and Mycobacterium tuberculosis Control. | mBio | 2021 | 34253059 | PubTator, text mining | PubMed |
| ASRGL1 Correlates With Immune Cell Infiltration in Hepatocellular Carcinoma and Can Serve as a Prognostic Biomarker. | Front Oncol | 2021 | 34249720 | PubTator, text mining | PubMed |
| Mesenchymal stem cells as professional actors in gastrointestinal cancer therapy: From Naïve to genetically modified. | Iran J Basic Med Sci | 2021 | 34249257 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=48